Temozolomide: the effect of once- and twice-a-day dosing on tumor tissue levels of the DNA repair protein O(6)-alkylguanine-DNA-alkyltransferase.
about
Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumorsDNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancerNSC666715 and Its Analogs Inhibit Strand-Displacement Activity of DNA Polymerase β and Potentiate Temozolomide-Induced DNA Damage, Senescence and Apoptosis in Colorectal Cancer CellsInhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumoursLethality to leukemia cell lines of DNA interstrand cross-links generated by Cloretazine derived alkylating species.Clinically relevant doses of chemotherapy agents reversibly block formation of glioblastoma neurospheres.Quantitative relationship between guanine O(6)-alkyl lesions produced by Onrigin™ and tumor resistance by O(6)-alkylguanine-DNA alkyltransferase.Role of MGMT as biomarker in colorectal cancer.Dose-dense temozolomide: is it still promising?A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancerEfficacy of protracted temozolomide dosing is limited in MGMT unmethylated GBM xenograft models.New (alternative) temozolomide regimens for the treatment of glioma.Glioblastoma multiforme therapy and mechanisms of resistance.A novel inhibitor of DNA polymerase beta enhances the ability of temozolomide to impair the growth of colon cancer cells.Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastoma.Effect of alternative temozolomide schedules on glioblastoma O(6)-methylguanine-DNA methyltransferase activity and survival.Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts.NICE verdict on Temozolomide: where next?
P2860
Q26765289-A5B065F9-330F-4E54-AE70-5B0E8D2BD2C4Q28477059-90ABFDAC-1F69-4560-8784-A6129D2B84DAQ28546932-1C38C707-CD79-44F0-88A1-2E8F1448C93EQ33396508-A37746AA-7C22-4D42-9EA4-76FF3EB96F59Q33924789-DD8A2E81-5460-40AD-91AE-DA295F5EC3A2Q34037067-99F688EE-6A98-4589-9CE1-7555A37C7162Q34178990-AE61D70C-732F-41B6-86F2-EB6128433B21Q34706115-9A8BE6A0-E641-4502-9FEF-74E2F3DFE645Q35943654-A8BD96A1-5CA8-4134-9878-535B5BC9C59FQ36667516-0B671C94-2A7A-47C6-A235-1223158B14B1Q36866006-63D04358-67EE-4DB2-AA31-1266DF15DCF6Q37261125-E10A63EF-90D3-4BCE-A38D-D236E1BF60A9Q37415954-7AC41F28-F586-4B06-AA9F-C0A29FBE49BEQ37485063-8C980C8E-7B53-4203-BAFA-072823F0F543Q38984857-9CB0E869-C7DC-462D-B955-E4E531D7204BQ39680548-020CF489-726F-46A1-8D3C-E1CEAD5DC81BQ39924899-098A210D-4B3B-4030-9620-9719030593CEQ43217464-6E10A2B4-CCAA-4AD6-BF7E-C9C0BCA759B6
P2860
Temozolomide: the effect of once- and twice-a-day dosing on tumor tissue levels of the DNA repair protein O(6)-alkylguanine-DNA-alkyltransferase.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Temozolomide: the effect of on ...... ls of the DNA repair protein O
@nl
Temozolomide: the effect of on ...... lguanine-DNA-alkyltransferase.
@ast
Temozolomide: the effect of on ...... lguanine-DNA-alkyltransferase.
@en
type
label
Temozolomide: the effect of on ...... ls of the DNA repair protein O
@nl
Temozolomide: the effect of on ...... lguanine-DNA-alkyltransferase.
@ast
Temozolomide: the effect of on ...... lguanine-DNA-alkyltransferase.
@en
prefLabel
Temozolomide: the effect of on ...... ls of the DNA repair protein O
@nl
Temozolomide: the effect of on ...... lguanine-DNA-alkyltransferase.
@ast
Temozolomide: the effect of on ...... lguanine-DNA-alkyltransferase.
@en
P2093
P1476
Temozolomide: the effect of on ...... ylguanine-DNA-alkyltransferase
@en
P2093
P304
P407
P577
2001-08-01T00:00:00Z